home / stock / pfe / pfe articles

PFE Articles, Pfizer Inc. - From 04/02/24

Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...
AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race | Benzinga

AstraZeneca Plc’s (NASDAQ:AZN) Chief Executive Pascal Soriot says the company achieved a significant milestone by reaching a s...
Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era | Benzinga

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) did not only earn billions of dollars from their COVID-19 leading products but also rose to fame for ...

Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Core & Main, Inc. (NYSE: CNM) is "right at the heart of this infr...

Ozempic Users Speak Out Over Side Effects, Lawsuits Against Novo Nordisk And Eli Lilly Surge | Benzinga

Scores of patients are reportedly taking legal action against pharmaceutical giants Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S...
Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease | Benzinga

An investigational gene therapy, dubbed scAAV9/JeT-GAN, for a rare neurodegenerative disease, giant axonal neuropathy (GAN), that begins in early c...

Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts | Benzinga

Money manager Cathie Wood’s Ark Invest has a favorite biotech holding now, going by the firm’s recent buying activity. What Happened: A...

BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials | Benzinga

BioNTech SE (NASDAQ: BNTX) is way past its glorious Covid-19 days, when it thrived with Pfizer Inc (NYSE: PFE) for saving the world from the pandem...
Why Is BioNTech Stock Trading Lower On Wednesday? | Benzinga

Pfizer Inc’s (NYSE:PFE) German partner, BioNTech SE (NASDAQ:BNTX), reported fourth-quarter 2023 EPS of fiscal year Q4 GAAP EPS of €1.90 ...

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B | Benzinga

Pfizer Inc (NYSE:PFE) plans to slash its stake to approximately 24% in Consumer healthcare giant Haleon Plc (NYSE:HLN)&nbs...

Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data | Benzinga

Thursday, Immuneering Corporation (NASDAQ:IMRX) revealed topline results from the ongoing Phase 1 portion of its Phase 1/2a trial of IMM-...
Previous 10 Next 10